T. Rantonen et al., Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates, ACT PAEDIAT, 90(3), 2001, pp. 278-281
The effects of maternal magnesium sulphate treatment on neonatal mineral st
atus and parathyroid hormone secretory response were studied in 8 exposed a
nd 27 control preterm infants during the first 2 wk of life, Antenatal magn
esium sulphate resulted in hypermagnesaemia during the first 3-7 d of life
without affecting other serum mineral concentrations.
Conclusion: Early hypermagnesaemia was associated with hypercalciuria durin
g the first 3 d and parathyroid hormone suppression up to the age of 2 wk i
n the exposed infants.